A new startup sets course against a constellation of rare diseases with a first shot repurposing the SIRP pathway

Despite some big advances in recent years, rare disease remains [...]

By |2022-12-05T18:39:02-05:00February 16, 2022|News Coverage|0 Comments
Read More

Star Therapeutics emerges with plans to treat rare diseases through a solar system of drug companies

The biotech has an unusual hub-and-spoke model that it believes [...]

By |2022-03-22T13:33:39-04:00February 16, 2022|News Coverage|0 Comments
Read More

Electra Therapeutics announces $84 million Series B financing and unveils its novel SIRP targeted therapies for immunological diseases and cancer

Company’s first-in-class approach to targeting of signal regulatory proteins (SIRP) [...]

By |2022-12-05T18:44:13-05:00February 16, 2022|Press Release|0 Comments
Read More

Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies

Drug discovery approach uncovers novel biology for treatments that can [...]

By |2022-12-05T18:39:45-05:00February 16, 2022|Press Release|0 Comments
Read More

© 2023 STAR Therapeutics Inc.

THANK YOU

We look forward to connecting with you